Tenecteplase in Stroke Patients Between 4.5 and 24 Hours

NCT03785678 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

THROMBOLYSIS

Interventions

BIOLOGICAL: Tenecteplase
OTHER: Placebo

Sponsor

Genentech, Inc.